Anixa Biosciences is trading 5.37% up now at $3.86, as broader biotechnology strength lifted the sector on August 25, 2026.
- Biotechnology ETF XBI gained 2.06% during regular trading, providing the clearest explanation for the after-hours move.
- The company highlighted upcoming September 9–11 Cantor Fitzgerald conference participation and positive vaccine and CAR-T progress on August 24.
- No new company-specific announcement or earnings release was identified on August 25.